188 related articles for article (PubMed ID: 563155)
21. Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I).
Bird TD; Ott J; Giblett ER; Chance PF; Sumi SM; Kraft GH
Ann Neurol; 1983 Dec; 14(6):679-84. PubMed ID: 6651251
[TBL] [Abstract][Full Text] [Related]
22. [Early diagnosis and differentiation of Charcot-Marie neural atrophy].
Lobzin VS; Saĭkova LA; Poliakova LA; Kosachev VD
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1601-5. PubMed ID: 6524176
[TBL] [Abstract][Full Text] [Related]
23. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
Beauvais K; Furby A; Latour P
Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
[TBL] [Abstract][Full Text] [Related]
24. Charcot-Marie-Tooth disease with sensorineural hearing loss--an autosomal dominant trait.
Kousseff BG; Hadro TA; Treiber DL; Wollner T; Morris C
Birth Defects Orig Artic Ser; 1982; 18(3B):223-8. PubMed ID: 7139106
[No Abstract] [Full Text] [Related]
25. [Usefulness Of electromyographic examination of families of patients affected with hypertrophic sensory-motor neuropathy (Charcot-Marie-Tooth disease). Preliminary results].
Fardin P; Micaglio GF; Angelini C; Negrin P; Siciliano G
Riv Neurobiol; 1984; 30(2-3):222-8. PubMed ID: 6544478
[No Abstract] [Full Text] [Related]
26. [Charcot-Marie-Tooth disease. Peroneal muscular atrophy].
Hagen T; Jensen D; Dietrichson P; Heiberg A
Tidsskr Nor Laegeforen; 1990 Oct; 110(24):3110-5. PubMed ID: 2237866
[TBL] [Abstract][Full Text] [Related]
27. Charcot-Marie-Tooth's disease with severe trophic and sensory disorders. Study of a case following along a half a century with anatomical studies.
Barraquer-Bordas L; Navarro C; Salisachs P
Acta Neurol Latinoam; 1981; 27(3-4):177-89. PubMed ID: 6965173
[TBL] [Abstract][Full Text] [Related]
28. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.
Bouhouche A; Birouk N; Azzedine H; Benomar A; Durosier G; Ente D; Muriel MP; Ruberg M; Slassi I; Yahyaoui M; Dubourg O; Ouazzani R; LeGuern E
Brain; 2007 Apr; 130(Pt 4):1062-75. PubMed ID: 17347251
[TBL] [Abstract][Full Text] [Related]
29. Controversy in genetic disorders.
Sybert VP
Arch Dermatol; 1981 Jul; 117(7):380-1. PubMed ID: 6455091
[No Abstract] [Full Text] [Related]
30. [Involvement of the optic nerve in neural muscular atrophy].
Reisecker F; Leblhuber F; Deisenhammer E
Wien Klin Wochenschr; 1985 Aug; 97(16):658-61. PubMed ID: 4060727
[TBL] [Abstract][Full Text] [Related]
31. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
[TBL] [Abstract][Full Text] [Related]
32. Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci.
Kochanski A; Kennerson M; Kawulak M; Ryniewicz B; Rowinska-Marcinska K; Walizada G; Nowakowski A; Hausmanowa-Petrusewicz I; Nicholson GA
Neurology; 2005 Feb; 64(3):533-5. PubMed ID: 15699389
[TBL] [Abstract][Full Text] [Related]
33. [The importance of studying stimulation parameters in amyotrophic lateral sclerosis and Charcot-Marie-Tooth neural amyotrophy].
Kyral V; Pára F
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(4):415-22. PubMed ID: 6971479
[No Abstract] [Full Text] [Related]
34. Malignant melanoma and Charcot-Marie-Tooth disease.
Greene MH; Mead GD; Reimer RR; Bergfeld WF; Fraumeni JF
Am J Med Genet; 1980; 5(1):69-71. PubMed ID: 7395902
[TBL] [Abstract][Full Text] [Related]
35. Palmoplantar keratoderma and Charcot-Marie-Tooth disease.
Rabbiosi G; Borroni G; Pinelli P; Cosi V
Arch Dermatol; 1980 Jul; 116(7):789-90. PubMed ID: 6446889
[TBL] [Abstract][Full Text] [Related]
36. Charcot-Marie-Tooth disease with Leber optic atrophy.
McLeod JG; Low PA; Morgan JA
Neurology; 1978 Feb; 28(2):179-84. PubMed ID: 563998
[TBL] [Abstract][Full Text] [Related]
37. [Electromyography in Charcot-Marie disease].
Zumstein V; Schneider C
Schweiz Arch Neurol Neurochir Psychiatr; 1982; 130(2):297-307. PubMed ID: 7134908
[No Abstract] [Full Text] [Related]
38. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A.
Lupski JR; Wise CA; Kuwano A; Pentao L; Parke JT; Glaze DG; Ledbetter DH; Greenberg F; Patel PI
Nat Genet; 1992 Apr; 1(1):29-33. PubMed ID: 1301995
[TBL] [Abstract][Full Text] [Related]
39. Charcot-Marie-Tooth disease in northern Finland.
Rantala H; Tolonen U; Myllylä V
Ann Clin Res; 1986; 18(3):154-9. PubMed ID: 3740791
[TBL] [Abstract][Full Text] [Related]
40. [Charcot-Marie neural amyotrophy (review)].
Savchenko IuN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1718-22. PubMed ID: 6098115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
